ArticleInternational journal of molecular sciences2022

A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling.

Sei-Ichi Tanuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.